Tarssanen L, Huikko M, Rossi M
Acta Med Scand. 1980;208(6):491-4. doi: 10.1111/j.0954-6820.1980.tb01236.x.
We present three aged female patients who fulfil the criteria of a syndrome that we call "amiloride hyponatremia". They became hyponatremic during amiloride + hydrochlorothiazide therapy. They needed diuretic therapy and tolerated well hydrochlorothiazide with potassium supplementation as potassium chloride. Patients with hyponatremia during diuretic therapy for cardiovascular diseases can be allocated to three groups: 1) Patients with edema and water retention due to severe impairment of cardiac function and decreased water clearance. They need diuretic therapy and water restriction. 2) Patients with "normal diuretic hyponatremia". Hypokalemia and extracellular volume contraction seem to be associated with this phenomenon, and the therapy involves discontinuing the necessary diuretic treatment. 3) Patients with "amiloride hyponatremia". They need diuretic treatment and tolerated thiazide therapy, but the hyponatremia can be corrected by changing amiloride to potassium supplementation. "Amiloride hyponatremia" is suggested to be due to a direct effect of amiloride + hydrochlorothiazide on the distal nephrons. The combination amiloride + hydrochlorothiazide must be used cautiously in elderly patients and the possibility of hyponatremia should be born in mind cases of vague symptoms and CNS disturbances.
我们报告了三名老年女性患者,她们符合一种我们称为“氨氯地平性低钠血症”综合征的标准。她们在氨氯地平和氢氯噻嗪联合治疗期间出现了低钠血症。她们需要利尿剂治疗,并且对补充氯化钾的氢氯噻嗪耐受性良好。心血管疾病利尿剂治疗期间出现低钠血症的患者可分为三组:1)因心功能严重受损和水清除率降低导致水肿和水潴留的患者。他们需要利尿剂治疗和限水。2)“正常利尿剂性低钠血症”患者。低钾血症和细胞外液量减少似乎与这种现象有关,治疗方法包括停用必要的利尿剂治疗。3)“氨氯地平性低钠血症”患者。他们需要利尿剂治疗,并且对噻嗪类治疗耐受性良好,但通过将氨氯地平换成补钾可纠正低钠血症。“氨氯地平性低钠血症”被认为是由于氨氯地平和氢氯噻嗪对远端肾单位的直接作用所致。氨氯地平和氢氯噻嗪联合用药在老年患者中必须谨慎使用,对于出现模糊症状和中枢神经系统紊乱的病例,应考虑到低钠血症的可能性。